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Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous 
system (CNS), in which CNS myelin becomes the target of an immune attack. MS is 
characterized by perivascular inflammatory lesions, demyelination, and axonal damage, 
but its immunopathogenesis is not yet well understood. Experimental autoimmune 
encephalomyelitis (EAE) is a widely used animal model for MS that serves to explore the 
pathogenesis of MS, including the involvement and importance of different cell types in 
induction of EAE. To investigate the role of the different antigen-presenting cells (APCs) 
in EAE induction and in T cell tolerance a new mouse model was generated in our 
laboratory (by T. Heinen; termed IiMOG), which allows the cell type-specific 
presentation of an encephalitogenic self-peptide of myelin oligodendrocyte glycoprotein 
(MOGp35-55) on MHC class II of B cells, macrophages, or dendritic cells (DCs). DCs 
are believed to induce both tolerance and immunity, depending on their maturation status 
as immature or mature, respectively. The role of B cells in induction or tolerization of 
immune responses has not been an area of intensive study to date. In this work we 
demonstrate that constitutive presentation of MOGp35-55 specifically by B cells leads to 
tolerance to EAE. Furthermore, transferred MOG-specific T cells are tolerized in vivo by 
naïve as well as by activated B cells. These T cells do not express classical early 
activation markers such as CD69 or CD44, but show an upregulation of the coinhibitory 
molecules CTLA-4, PD-1, BTLA, and CD5, which are involved in tolerance and negative 
regulation of T cells. B cell-tolerized MOG-specific T cells appear unresponsive, 
dysfunctional, and become highly susceptible to activation-induced cell death (AICD) – a 
process that is not prevented by blocking of the upregulated inhibitory receptors. 
Proliferation of T cells after interaction with MOG-presenting B cells was slightly 
increased upon blockade of CTLA-4, but not PD-1 or CD5. 
Inducible presentation of MOGp35-55 by resting DCs also induces tolerance to EAE. In 
transfer experiments, however, total DCs presenting MOGp35-55 induce proliferation 
and activation of CD4+ MOG-specific T cells. Previously, immature DCs have been 
shown to induce the generation of regulatory T cells (Tregs). The B cell-tolerized T cells 
showed increased or decreased expression levels of the inhibitory cytokine TGF-β and its 
inhibitor Smad7, respectively, yet no suppressive activity was detectable in vitro after 
reaching the tolerant state. The increase in TGF-β expression, a hallmark of the induced 
Treg lineage, was therefore not a result of the tolerized cells differentiating into Tregs. 
Nevertheless, we were able to demonstrate a role for B cells in the homeostasis of Treg 
cells and provide evidence for Tregs being less sensitive to apoptosis than MOG-specific 
conventional CD4+ T cells. 
 
